Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kin-Hoe Chow

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Nature Cell Biology|November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistanceYihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Nature Communications|April 28, 2025
Investigative needle core biopsies support multimodal deep-data generation in glioblastomaKenny K H Yu, Sreyashi Basu, Gerard Baquer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Investigative needle core biopsies for multi-omics in GlioblastomaKenny K H Yu, Sreyashi Basu, Gerard Baquer, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancers|June 2, 2021
Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient <i>TP53</i> Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 InteractionsKatherine N Lynch, Joyce F Liu, Nikolas Kesten, et al.
JCI Insight|August 30, 2022
VRK1 as a synthetic lethal target in VRK2 promoter-methylated cancers of the nervous systemJonathan So, Nathaniel W Mabe, Bernhard Englinger, et al.
Nature Cell Biology|November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistanceYihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Nature Communications|April 28, 2025
Investigative needle core biopsies support multimodal deep-data generation in glioblastomaKenny K H Yu, Sreyashi Basu, Gerard Baquer, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Investigative needle core biopsies for multi-omics in GlioblastomaKenny K H Yu, Sreyashi Basu, Gerard Baquer, et al.
Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Pageof 3